Covered recipient · General Payments record
VIVIAN OD LA
Eye and Vision Services Providers Optometrist
General Payments · PY2022–2024
$1,966.46
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $600.71 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| RxSight Inc | $155.79 | 2 |
| Amgen Inc. | $97.67 | 1 |
| ABBVIE INC. | $88.38 | 4 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $69.17 | 3 |
| GLAUKOS CORPORATION | $63.57 | 2 |
| Dompe US, Inc. | $32.40 | 1 |
| Bausch & Lomb Americas Inc. | $25.36 | 1 |
| Genentech USA, Inc. | $24.03 | 1 |
| Tarsus Pharmaceuticals, Inc. | $22.43 | 1 |
| Harrow Eye, LLC | $21.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.64 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104124654 | CMS |
| ABBVIE INC. | $13.17 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104124656 | CMS |
| ABBVIE INC. | $21.95 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104124658 | CMS |
| ABBVIE INC. | $26.62 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104124660 | CMS |
| Amgen Inc. | $97.67 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115842312 | CMS |
| Bausch & Lomb Americas Inc. | $25.36 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140465651 | CMS |
| Dompe US, Inc. | $32.40 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151418125 | CMS |
| Genentech USA, Inc. | $24.03 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133130802 | CMS |
| Glaukos Corporation | $24.36 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151984024 | CMS |
| Glaukos Corporation | $39.21 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151980240 | CMS |
| Harrow Eye, LLC | $21.91 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145607340 | CMS |
| RxSight Inc | $23.71 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144220392 | CMS |
| RxSight Inc | $132.08 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144220394 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $19.12 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152211069 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $24.74 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152211071 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $25.31 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152211073 | CMS |
| Tarsus Pharmaceuticals, Inc. | $22.43 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139110077 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.